文献速递临床试验与 GCP

针刺治疗多囊卵巢综合征伴胰岛素抵抗女性胰岛素敏感性的随机对照试验研究方案

Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-03-09

本研究为多中心、对照、双盲、随机临床试验,计划纳入342例多囊卵巢综合征(PCOS)伴胰岛素抵抗(IR)患者,随机分为真针刺+二甲双胍安慰剂组、假针刺+二甲双胍组和假针刺+二甲双胍安慰剂组,针刺每周3天共48次治疗、持续4个月,二甲双胍0.5g/片每日三次共4个月,主要结局为口服葡萄糖耐量试验和胰岛素释放试验评估的HOMA-IR变化及改善率。

要点

  • 多中心双盲随机对照试验,计划纳入342例PCOS伴IR女性,比较真针刺、假针刺与二甲双胍对胰岛素敏感性的影响。
  • 针刺干预为每周3天、4个月内共48次治疗;二甲双胍0.5g/片每日三次、共4个月。
  • 主要结局为OGTT和胰岛素释放试验评估的HOMA-IR变化及HOMA-IR改善率。

核心结论

  • 本研究将探讨针刺对PCOS伴IR女性胰岛素敏感性的影响,并与二甲双胍和假针刺进行比较。
  • 将检验在骨骼肌部位进针并手法及电刺激的真针刺,在改善PCOS伴IR女性胰岛素敏感性方面是否优于二甲双胍和仅浅表进针、无手法或电刺激的假针刺。

研究设计与样本

  • 多中心、对照、双盲、随机临床试验,计划纳入342例诊断为PCOS伴IR的患者。
  • 参与者随机分为三组:真针刺+二甲双胍安慰剂组、假针刺+二甲双胍组、假针刺+二甲双胍安慰剂组。
  • 参与者和评估者设盲;筛查访视完成后通过中央随机化系统进行随机化。
  • 针刺干预每周3天,4个月内共48次治疗;二甲双胍(0.5g/片)或安慰剂每日三次、共4个月。

主要发现

  • 主要结局指标为口服葡萄糖耐量试验(OGTT)和胰岛素释放试验(Ins)评估的稳态模型评估胰岛素抵抗(HOMA-IR)变化及HOMA-IR改善率。
  • 次要结局指标包括稳态模型评估β细胞功能(HOMA-β)、葡萄糖和胰岛素曲线下面积、规律月经周期和排卵频率、体成分、代谢指标、激素指标、问卷、副作用情况以及治疗期望和可信度。
  • 结局指标在基线、治疗结束时及末次针刺治疗后3个月收集。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our prospective pilot study of acupuncture affecting insulin sensitivity on polycystic ovary syndrome (PCOS) combined with insulin resistance (IR) showed that acupuncture had a significant effect on improving the insulin sensitivity of PCOS. But there is still no randomized controlled trial to determine the effect of acupuncture on the insulin sensitivity in women with PCOS and IR. In this article, we present the protocol of a randomized controlled trial to compare the effect of true acupuncture on the insulin sensitivity of these patients compared with metformin and sham acupuncture. Acupuncture may be an effective therapeutic alternative that is superior to metformin and sham acupuncture in improving the insulin sensitivity of PCOS combined with IR. METHODS: This study is a multi-center, controlled, double-blind, and randomized clinical trial aiming to evaluate the effect of acupuncture on the insulin sensitivity in PCOS combined with IR. In total 342 patients diagnosed with PCOS and IR will be enrolled. Participants will be randomized to one of the three groups: (1) true acupuncture + metformin placebo; (2) sham acupuncture + metformin, and (3) sham acupuncture + metformin placebo. Participants and assessors will be blinded. The acupuncture intervention will be given 3 days per week for a total of 48 treatment sessions during 4 months. Metformin (0.5 g per pill) or placebo will be given, three times per day, and for 4 months. Primary outcome measures are changes in homeostasis model assessment of insulin resistance (HOMA-IR) and improvement rate of HOMA-IR by oral glucose tolerance test (OGTT) and insulin releasing test (Ins). Secondary outcome measures are homeostasis model assessment-β (HOMA-β), area under the curve for glucose and insulin, frequency of regular menstrual cycles and ovulation, body composition, metabolic profile, hormonal profile, questionnaires, side effect profile, and expectation and credibility of treatment. Outcome measures are collected at baseline, at the end of treatments, and 3 months after the last acupuncture treatment. On completion of the screening visit, randomization will be conducted using a central randomization system. DISCUSSION: This study will investigate the effects of acupuncture on the insulin sensitivity of PCOS and IR women compared with metformin and sham acupuncture. We will test whether true acupuncture with needles placed in skeletal muscles and stimulated manually and by electrical stimulation is more effective than metformin and sham acupuncture with superficial needle placement with no manual or electrical stimulation in improving the insulin sensitivity in PCOS women with IR. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02491333 ; Chinese Clinical Trial Registry, ChiCTR-ICR-15006639. Registered on 24 June 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li J, Ng EH, Stener-Victorin E, et al. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial. Trials. 2017. PMID: 28274268. doi:10.1186/s13063-017-1854-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。